Want to see ARDT full AI Analyst Report?
ARDT Stock Chart & Stats
$10.64
$0.22(2.11%)
At close: 4:00 PM EDT
$10.64
$0.22(2.11%)
Day’s Range― - ―
52-Week Range$7.71 - $15.48
Previous CloseN/A
Volume957.16K
Average Volume (3M)538.02K
Market Cap
$1.54B
Enterprise Value$3.28K
Total Cash (Recent Filing)$609.69M
Total Debt (Recent Filing)$2.29B
Price to Earnings (P/E)11.2
Beta0.55
Next Earnings
Aug 04, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.95
Shares Outstanding143,350,040
10 Day Avg. Volume477,926
30 Day Avg. Volume538,017
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)0.74
Price to Sales (P/S)0.20
P/FCF Ratio4.81
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$12.19Price Target Upside14.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)1.08
Revenue Forecast (FY)$6.45B
Bulls Say, Bears Say
Bulls Say
Material DeleveragingSubstantial reduction in leverage meaningfully lowers balance-sheet risk and interest burden, increasing financial flexibility. This supports durable capacity for capex, ambulatory expansion, and absorbing cyclical shocks while underpinning continued investment in margin initiatives.
IMPACT Program Driving Cost SavingsA structured, enterprise-wide cost program delivering $55M of recurring savings boosts sustainable margins. Durable P&L benefits from vendor consolidation, staffing precision and labor reductions can permanently lower unit costs and fund reinvestment or debt paydown.
Consistent Top-line GrowthRepeated revenue expansion and positive admissions trajectory indicate enduring demand and scale. Stable top-line growth supports operating leverage, funds margin-improvement programs, and underpins steady expansion into higher-margin ambulatory and virtual care channels.
Bears Say
Thin, Inconsistent ProfitabilityLow and variable net margins limit free cash generation and return potential, making results sensitive to cost inflation, payer shifts, and one-time items. Persistent margin pressure constrains reinvestment, reduces buffer for adverse volume or reimbursement trends.
Moderate Cash Conversion And FCF SoftnessOnly moderate cash conversion and a recent drop in FCF weaken self-funding capacity for capex and strategic moves. If conversion remains below earnings, the company will depend more on liquidity or slower deleveraging, reducing optionality for expansion or higher payouts.
Exchange/payer Mix HeadwindStructural shifts toward higher patient cost-sharing and exchange mix reduce revenue throughput and raise exposure to disenrollments and bad debt. This persistent payer mix pressure can erode realized margins and complicate longer-term planning for volume-driven initiatives.
Ardent Health Partners, Inc. News
ARDT FAQ
What was Ardent Health Partners, Inc.’s price range in the past 12 months?
Ardent Health Partners, Inc. lowest stock price was $7.71 and its highest was $15.48 in the past 12 months.
What is Ardent Health Partners, Inc.’s market cap?
Ardent Health Partners, Inc.’s market cap is $1.54B.
When is Ardent Health Partners, Inc.’s upcoming earnings report date?
Ardent Health Partners, Inc.’s upcoming earnings report date is Aug 04, 2026 which is in 3 days.
How were Ardent Health Partners, Inc.’s earnings last quarter?
Ardent Health Partners, Inc. released its earnings results on May 05, 2026. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.191 by $0.089.
Is Ardent Health Partners, Inc. overvalued?
According to Wall Street analysts Ardent Health Partners, Inc.’s price is currently Undervalued.
Does Ardent Health Partners, Inc. pay dividends?
Ardent Health Partners, Inc. does not currently pay dividends.
What is Ardent Health Partners, Inc.’s EPS estimate?
Ardent Health Partners, Inc.’s EPS estimate is 0.18.
How many shares outstanding does Ardent Health Partners, Inc. have?
Ardent Health Partners, Inc. has 143,350,040 shares outstanding.
What happened to Ardent Health Partners, Inc.’s price movement after its last earnings report?
Ardent Health Partners, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.191. Following the earnings report the stock price went down -7.502%.
Which hedge fund is a major shareholder of Ardent Health Partners, Inc.?
Currently, no hedge funds are holding shares in ARDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ardent Health Partners, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.19 (14.54% Upside)
$12.19 (14.54% Upside)
Blogger Sentiment
Bullish
ARDT Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 699.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $186.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.78%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.95%
Trailing 12-Months
Company Description
Ardent Health Partners, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
ARDT Company Deck
ARDT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: solid top-line growth (+7% revenue), strong adjusted EBITDA improvement (+26%, or +15% excluding a one-time investment gain), meaningful margin expansion (110 bps), demonstrable cost and labor discipline (contract labor down >40%, SW&B per AA improvements), and healthy liquidity and leverage metrics. Management acknowledged near-term volume headwinds from weather and lighter flu, exchange-related revenue pressure (~$35M estimated headwind), higher professional fees and medical malpractice premium increases, and ongoing denial-management work. On balance, the positive execution against the IMPACT program, margin gains, cash/liquidity strength, and disciplined growth initiatives outweigh the noted challenges.View all ARDT earnings summariesARDT Stock 12 Month Forecast
Average Price Target
$12.19
▲(14.54% Upside)
Technical Analysis
Acadia Healthcare
―
Brookdale Senior Living
―
National Healthcare
―
―
Aveanna Healthcare Holdings
―
Ownership Overview
2.76% Insiders
3.72% Mutual Funds
0.24% Other Institutional Investors
90.30% Public Companies and
Individual Investors